Answers are grounded in this paper and cite their sources.
Aim: Review of current literature regarding infection rates following intravitreal dexamethasone implant shows very little real-world data to date. Comparisons with infection rates following anti-VEGF or triamcinolone injections may not be clinically useful due to differing procedures and localised drug effects. We report the first direct clinical data on endophthalmitis rates following intravitreal dexamethasone implants in a tertiary eye unit in the UK. Methods: Retrospective study of electronic patient records of all endophthalmitis cases between March 2010 and March 2018, with identification of dexamethasone-related cases. Review of treatment given, visual outcomes and possible risk factors. Results: From 947 documented injections, 3 endophthalmitis cases were identified, giving a post-operative endophthalmitis rate of 0.32%. Conclusion: Our data show a higher rate than previously published. Discussion of the cases reveals one case in a previously vitrectomised eye with post-operative wound leak. This may represent a risk factor for infection, but small numbers currently prevent useful statistical analysis. We discuss modifications to the protocol in our unit based on our experiences and available evidence.
No takes yet. Share an insight, caveat, or question.
Clarke et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: